Halper Sadeh LLC Is Investigating Whether RLYB, TALK, UNF Are Obtaining Fair Deals For Their Shareholders

2026-03-19 08:17:12

(MENAFN- GlobeNewsWire - Nasdaq) Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation.

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Rallybio Corporation (NASDAQ: RLYB)'s merger with Candid Therapeutics, Inc. Upon completion of the proposed transaction, Rallybio shareholders are expected to own approximately 3.65% of the combined company. If you are a Rallybio shareholder, click here to learn more about your rights and options.

Talkspace, Inc. (NASDAQ: TALK)'s sale to Universal Health Services, Inc. for $5.25 per share. If you are a Talkspace shareholder, click here to learn more about your rights and options

UniFirst Corporation (NYSE: UNF)'s sale to Cintas Corporation for $155.00 in cash and 0.7720 shares of Cintas stock for each UniFirst share. If you are a UniFirst shareholder, click here to learn more about your rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
...
...

MENAFN19032026004107003653ID1110883095

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.